These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6031473)
1. Pharmacology of ethyl dibunate, a new antitussive agent. Shemano I; Beiler JM; Hitchens JT Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):410-24. PubMed ID: 6031473 [No Abstract] [Full Text] [Related]
2. Gitan, 2-(beta-diethylaminoethyl)-3-phenylphthalimidine phosphate an antitussive agent. Hanna C Arch Int Pharmacodyn Ther; 1970 May; 185(1):47-52. PubMed ID: 5470023 [No Abstract] [Full Text] [Related]
3. Antitussive activity and other related pharmacological properties of 2-allyoxy-4-chloro-N-(2-diethylaminoethyl) benzamide. Kasé Y; Kawasaki A; Miyata T; Tsumagari T; Yuizono T Jpn J Pharmacol; 1966 Dec; 16(4):342-52. PubMed ID: 5298923 [No Abstract] [Full Text] [Related]
4. [Comparative pharmacological study of antitussive preparations derived from piperazine]. Le Douarec JC; Régnier G; Canévari R Arzneimittelforschung; 1965 Nov; 15(11):1330-7. PubMed ID: 5899868 [No Abstract] [Full Text] [Related]
5. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent. Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320 [No Abstract] [Full Text] [Related]
6. Some observations on the pharmacology of mitragynine. Macko E; Weisbach JA; Douglas B Arch Int Pharmacodyn Ther; 1972; 198(1):145-61. PubMed ID: 4626477 [No Abstract] [Full Text] [Related]
7. Pharmacological activities of a new antitussive agent: morphethylbutyne (2-phenoxy-isobutyric acid, 2-morpholine-ethyl ester). Marchetti E; Samueli F; Stucchi F Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):400-6. PubMed ID: 4242953 [No Abstract] [Full Text] [Related]
8. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent. Tersteege HM; Funcke AB; Louwerse WJ; Nauta WT Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):314-33. PubMed ID: 5926874 [No Abstract] [Full Text] [Related]
9. On the site of antitussive action of 1-(2-benzylphenoxy)-2-piperidinopropane phosphate (Pirexyl). Yamatsu K; Otsu K; Kase Y; Miyata T; Yuizono T Jpn J Pharmacol; 1967 Dec; 17(4):538-49. PubMed ID: 5301345 [No Abstract] [Full Text] [Related]
10. [Antitussive study on conscious rabbits. II. Inhibition of the cough center]. Savini EC; Moulin MA; Herrou MJ Therapie; 1968; 23(3):491-509. PubMed ID: 5741502 [No Abstract] [Full Text] [Related]
11. On the sites of antitsive action of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3). Kasé Y; Wakita Y; Yuizono T; Kito G; Kikuchi K Arzneimittelforschung; 1970 Jan; 20(1):37-43. PubMed ID: 5467446 [No Abstract] [Full Text] [Related]
12. The general pharmacology of a novel antitussive compound RU 20201. Pickering RW; James GW Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol). Kobayashi S; Hasegawa K; Mori M; Takagi H Arzneimittelforschung; 1970 Jan; 20(1):43-6. PubMed ID: 5467447 [No Abstract] [Full Text] [Related]
14. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)]. Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383 [No Abstract] [Full Text] [Related]
15. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system. Cosnier D; Hache J; Labrid C; Rispat G Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic and toxicologic studies of m-(1-methyl-3-propyl-3-pyrrolidinyl)phenol (CI-572), an analgetic and antitussive agent. Winder CV; Welford M; Wax J; Kaump DH J Pharmacol Exp Ther; 1966 Oct; 154(1):161-75. PubMed ID: 4958887 [No Abstract] [Full Text] [Related]
17. [Electrophysiological study on the site of action of antitussives, with particular reference to oxymetebanol, a new antitussive]. Mori M; Sakai Y; Hara T Nihon Yakurigaku Zasshi; 1973 Jan; 69(1):163-75. PubMed ID: 4737517 [No Abstract] [Full Text] [Related]
18. [Pharmacological properties of noscapine]. Sukhinina GP Farmakol Toksikol; 1968; 31(6):702-5. PubMed ID: 4388890 [No Abstract] [Full Text] [Related]
19. Pharmacological studies on dl-glaucine phosphate as an antitussive. Kasé Y; Kawaguchi M; Takahama K; Miyata T; Hirotsu I; Hitoshi T; Okano Y Arzneimittelforschung; 1983; 33(7):936-46. PubMed ID: 6354197 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of a new antitussive agent: meprotixol (N 7020). Hougs W; Nielsen IM; Norn S; Nymark M Acta Pharmacol Toxicol (Copenh); 1966; 24(1):3-23. PubMed ID: 6012748 [No Abstract] [Full Text] [Related] [Next] [New Search]